1. Home
  2. PRPO vs RETO Comparison

PRPO vs RETO Comparison

Compare PRPO & RETO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPO
  • RETO
  • Stock Information
  • Founded
  • PRPO N/A
  • RETO 1999
  • Country
  • PRPO United States
  • RETO China
  • Employees
  • PRPO N/A
  • RETO N/A
  • Industry
  • PRPO Biotechnology: Laboratory Analytical Instruments
  • RETO Multi-Sector Companies
  • Sector
  • PRPO Industrials
  • RETO Consumer Discretionary
  • Exchange
  • PRPO Nasdaq
  • RETO Nasdaq
  • Market Cap
  • PRPO 22.0M
  • RETO 24.7M
  • IPO Year
  • PRPO N/A
  • RETO 2017
  • Fundamental
  • Price
  • PRPO $13.80
  • RETO $2.09
  • Analyst Decision
  • PRPO
  • RETO
  • Analyst Count
  • PRPO 0
  • RETO 0
  • Target Price
  • PRPO N/A
  • RETO N/A
  • AVG Volume (30 Days)
  • PRPO 8.1K
  • RETO 47.1K
  • Earning Date
  • PRPO 08-14-2025
  • RETO 08-19-2025
  • Dividend Yield
  • PRPO N/A
  • RETO N/A
  • EPS Growth
  • PRPO N/A
  • RETO N/A
  • EPS
  • PRPO N/A
  • RETO N/A
  • Revenue
  • PRPO $20,029,000.00
  • RETO $1,828,976.00
  • Revenue This Year
  • PRPO N/A
  • RETO N/A
  • Revenue Next Year
  • PRPO N/A
  • RETO N/A
  • P/E Ratio
  • PRPO N/A
  • RETO N/A
  • Revenue Growth
  • PRPO 26.67
  • RETO N/A
  • 52 Week Low
  • PRPO $3.90
  • RETO $1.75
  • 52 Week High
  • PRPO $16.89
  • RETO $18.20
  • Technical
  • Relative Strength Index (RSI)
  • PRPO 49.26
  • RETO 37.83
  • Support Level
  • PRPO $13.92
  • RETO $2.00
  • Resistance Level
  • PRPO $14.65
  • RETO $2.23
  • Average True Range (ATR)
  • PRPO 0.36
  • RETO 0.20
  • MACD
  • PRPO -0.21
  • RETO -0.01
  • Stochastic Oscillator
  • PRPO 0.00
  • RETO 10.59

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

About RETO ReTo Eco-Solutions Inc.

ReTo Eco-Solutions Inc is a manufacturer and distributor of eco-friendly construction materials and fly-ash, as well as equipment used to produce these eco-friendly construction materials. The company engaged in providing consultation, design, project implementation and construction of urban ecological environments for capturing, controlling and re-using rainwater. It operates through four segments namely Machinery and Equipment sales, Construction materials sales, Municipal Construction Projects, and Technology Consulting and other services. The company earns its revenue from Machinery and Equipment sales segment. Geographically, it derives a majority of its revenue from China.

Share on Social Networks: